Search

Your search keyword '"Fisher, David"' showing total 309 results

Search Constraints

Start Over You searched for: Author "Fisher, David" Remove constraint Author: "Fisher, David" Database ScienceDirect Remove constraint Database: ScienceDirect
309 results on '"Fisher, David"'

Search Results

1. Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

7. DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

8. Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

10. Efficacy and moderators of efficacy of cognitive behavioural therapies with a trauma focus in children and adolescents: an individual participant data meta-analysis of randomised trials

11. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

12. Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

13. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

14. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials

16. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

22. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data

23. CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism

25. Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

33. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

34. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

35. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

37. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

38. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

40. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

43. The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data

44. Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study

Catalog

Books, media, physical & digital resources